Vol. 2 No. 1 (2011): Volume 2: Cancer

Vol. 2 No. 1 (2011)

Published June 1, 2011
Volume 2: Cancer

This volume encompasses various topics in cancer research and treatment. Sub themes in this volume include:

Advancements in cancer research initiatives across Canada
Public policy and management of cancer
Research advances in the molecular etiology of cancer

Full Issue
Volume 2

News

Aida Sivro
Page 14-Page 15
Preventing the epidemic. Campaign to Control Cancer
https://doi.org/10.29173/hsi66
pdf
Anita Liu
Page 16-Page 17
Advancements in Epigenetic Research and Its Role in Cancer Therapy
https://doi.org/10.29173/hsi67
pdf
Chan M. Lee
Page 18-Page 19
Immunotherapy Research in Canada: Where Do We Stand?
https://doi.org/10.29173/hsi68
pdf
Janis Geary
Page 20-Page 21
New Alberta Coalition Aims to Tackle Cancer Through Healthy Public Policy
https://doi.org/10.29173/hsi69
pdf
Megan Dodd
Page 22-Page 23
Cyberknife Offers Novel Non-Invasive & Non- Surgical Cancer Treatment Option to Canadians
https://doi.org/10.29173/hsi70
pdf
Rebecca Cheung
Page 24-Page 25
Men of Movember and Their Motivations
https://doi.org/10.29173/hsi71
pdf
Sean McFadden
Page 26-Page 27
McMaster Breakthrough May One Day Decrease Patient Reliance on Blood Donors
https://doi.org/10.29173/hsi72
pdf

Ask an Expert

James J. Rusthoven
Page 28-Page 31
In search for effective treatment for human diseases, should researchers be permitted to use embryonic stem cells within their research programs?
https://doi.org/10.29173/hsi47
pdf
Nicholas D. Vesprini
Page 32-Page 35
The ethics of animal research: A neuroscientist’s view
https://doi.org/10.29173/hsi48
pdf

Main Submissions

Anthony J. Apostoli
Page 36-Page 37
Nanotechnology and the promise for enhanced cancer chemotherapy
https://doi.org/10.29173/hsi49
pdf
Carly Barron
Page 38-Page 39
From diabetes to cancer: New applications for targeting AMPK in the clinical setting
https://doi.org/10.29173/hsi50
pdf
Taylor F. Bureyko, Rachel A. Murphy
Page 40-Page 41
Advancing cancer treatment: A move towards individualized therapy
https://doi.org/10.29173/hsi51
pdf
Liana Dedina
Page 42-Page 43
Aurora kinases: A novel target for drug development
https://doi.org/10.29173/hsi52
pdf
Robert L. Myette
Page 44-Page 45
Getting ‘JAK’ed about PI3K signaling in metastatic colorectal cancer
https://doi.org/10.29173/hsi53
pdf
Waqas U. Khan, Diane Blonski
Page 46-Page 47
The global disparity surrounding cancer treatment: How can the gap be closed?
https://doi.org/10.29173/hsi54
pdf
Deepa Singal, Tannis Erickson
Page 48-Page 49
Is population based screening mammography starting at 40 justifiable? Benefits, risks and common sense
https://doi.org/10.29173/hsi55
pdf
Diane Blonski, Waqas U. Khan
Page 50-Page 51
Prevention is key to halting the global silent killer – cancer
https://doi.org/10.29173/hsi56
pdf
Lindsay Kobayashi
Page 52-Page 53
The future of primary cancer prevention in Canada: Reaching for every ounce of prevention means reaching for equity
https://doi.org/10.29173/hsi57
pdf
Michelle Cleghorn
Page 54-Page 55
Public engagement in cancer control in Canada
https://doi.org/10.29173/hsi58
pdf
Ngoc-Thy Dinh
Page 56-Page 57
To screen or not to screen?
https://doi.org/10.29173/hsi59
pdf
Sara Suliman
Page 58-Page 59
The malignant impact of socio-economic disparities
https://doi.org/10.29173/hsi60
pdf
Sasi Shanmugaraj, Geeth C. Gunawardana
Page 60-Page 61
Overcoming sociocultural barriers to clinical breast examinations in South Asian immigrant women living in Canada
https://doi.org/10.29173/hsi61
pdf
Ashley Kornblum
Page 62-Page 63
Adherence to exercise in cancer survivors
https://doi.org/10.29173/hsi62
pdf
Angela Zwiers
Page 64-Page 65
Survivor?...The problem with labeling paediatric brain tumour “survivors”
https://doi.org/10.29173/hsi63
pdf
Sobia Khan
Page 66-Page 67
Coping with cancer: Improving mental health support services in cancer care
https://doi.org/10.29173/hsi64
pdf
Timothy W. Buckland
Page 68-Page 69
Lost in Transition: A young adult cancer survivor’s perspective on life after cancer
https://doi.org/10.29173/hsi65
pdf